James B. Hawkins - 15 Feb 2022 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role: Director
Signature: /s/ James Hawkins
Issuer symbol: IRMD
Transactions as of: 15 Feb 2022
Net transactions value: -$460,173
Form type: 4
Filing time: 17 Feb 2022, 16:05:27 UTC
Previous filing: 09 Dec 2021
Next filing: 08 Jul 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IRMD	Common Stock	Award	$13,973	+9,441	+44%	$1.48	30,931	15 Feb 2022	Direct	F1
transaction	IRMD	Common Stock	Sale	$474,146	-9,441	-31%	$50.22	21,490	15 Feb 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IRMD	Stock Options (Right to Buy)	Options Exercise	$0	-9,441	-100%	$0.000000^*	0	15 Feb 2022	Common Stock	9,441	$1.48	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
F2	This transaction was executed in multiple trades at prices ranging from $50.20 to $50.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.